AZD4547 10mg 10mg | Purity Not Available
Adooq Bioscience
AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier PageAZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier PagePF-04929113 (SNX-5422) is orally bioavailable heat shock protein 90 (Hsp90) inhibitor.
More Information Supplier PagePF-04929113 (SNX-5422) is orally bioavailable heat shock protein 90 (Hsp90) inhibitor.
More Information Supplier PageJTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
More Information Supplier PageJTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PageZM 336372 is a potent ATP-competitive inhibitor of Raf-1 in vitro (IC50 = 70 nM) with the paradoxical effect of inducing >100-fold activation of Raf-1 in whole cells.
More Information Supplier PageZM 336372 is a potent ATP-competitive inhibitor of Raf-1 in vitro (IC50 = 70 nM) with the paradoxical effect of inducing >100-fold activation of Raf-1 in whole cells.
More Information Supplier Page